Ditchcarbon
  • Contact
  1. Organizations
  2. Antengene
Public Profile
Pharmaceutical Preparation Manufacturing
CN
updated 3 days ago

Antengene

Company website

Antengene Corporation Limited, headquartered in China, is a pioneering biopharmaceutical company focused on the development and commercialisation of innovative therapies for cancer treatment. Founded in 2017, Antengene has rapidly established itself in the oncology sector, with a strong emphasis on precision medicine and targeted therapies. The company operates primarily in Asia-Pacific regions, aiming to address unmet medical needs through its robust pipeline of novel drug candidates. Antengene's core products include a range of innovative therapies that leverage cutting-edge technology, setting them apart in a competitive market. With notable achievements in clinical trials and strategic partnerships, Antengene is positioned as a key player in the biopharmaceutical industry, committed to improving patient outcomes and advancing cancer care globally.

DitchCarbon Score

How does Antengene's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

25

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

33

Industry Benchmark

Antengene's score of 25 is lower than 61% of the industry. This can give you a sense of how well the company is doing compared to its peers.

39%

Let us know if this data was useful to you

Antengene's reported carbon emissions

Antengene, headquartered in China (CN), has set ambitious climate commitments aimed at achieving Net Zero by 2050. The company has outlined a comprehensive strategy that encompasses all scopes of emissions, focusing on both operational and financed emissions. This commitment was formalised in December 2021, with a clear roadmap established to guide their efforts towards sustainability. As of now, there is no specific carbon emissions data available for Antengene, indicating a potential area for improvement in transparency and reporting. However, the company's long-term goal reflects a proactive approach to addressing climate change and reducing its environmental impact. Antengene's commitment to Net Zero by 2050 positions it within the growing trend of organisations prioritising sustainability and climate responsibility. The absence of current emissions data highlights the importance of establishing a baseline for future reporting and tracking progress against their climate targets.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Antengene's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Antengene is in CN, which we do not have grid emissions data for.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Antengene is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Merck And Co

US
•
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

Pfizer

US
•
Pharmaceutical Preparation Manufacturing
Updated about 15 hours ago

Bristol-Myers Squibb

US
•
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

Amgen

US
•
Pharmaceutical Preparation Manufacturing
Updated about 3 hours ago

Gilead Sciences

US
•
Pharmaceutical Preparation Manufacturing
Updated 2 days ago

Astra Zeneca

GB
•
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251018.1
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy